The Metra system has been approved in the U.S., Europe, Canada, and Australia and has been utilized in over 5,000 liver transplants.
Company Description
OrganOx is a company that has developed the Metra organ transplant system, a normothermic machine perfusion platform technology that keeps donor livers in a metabolically active state outside the body, allowing for functional assessment prior to transplant.
Market
Organ Transplant Technology
Location
United Kingdom
Coinvestors
HealthQuest Capital, BGF, Lauxera Capital Partners, Sofina, Soleus Capital, Avidity Partners, University of Oxford, Technikos, Oxford Technology and Innovations Fund, Longwall Ventures